Generate Biomedicines, Inc.
GENB
$15.64
$0.614.06%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.46% | -- | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -31.53% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | -12.17% | -- | |||
|
|
|||||
| Total Current Assets | -12.17% | -- | |||
| Net Property, Plant & Equipment | -3.77% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 90.90% | -- | |||
| Total Assets | -10.24% | -- | |||
|
|
|||||
| Total Accounts Payable | -26.13% | -- | |||
| Total Accrued Expenses | 34.38% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -4.50% | -- | |||
| Total Finance Division Other Current Liabilities | -25.30% | -- | |||
| Total Other Current Liabilities | -25.30% | -- | |||
| Total Current Liabilities | -3.00% | -- | |||
|
|
|||||
| Total Current Liabilities | -3.00% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -4.48% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | -4.77% | -- | |||
|
|
|||||
| Common Stock & APIC | 0.69% | -- | |||
| Retained Earnings | -9.12% | -- | |||
| Treasury Stock & Other | -637.50% | -- | |||
| Total Common Equity | -11.41% | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | -11.41% | -- | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -11.41% | -- | |||
|
|
|||||